PRMT2 and acute myeloid leukemia: Reanalysis of exome sequencing data from 105 patients within the same cohort, to score for mutations of known AML genes, does not reveal differences between high vs low PRMT2 expression groups either in deciles (n = 10, Fig. 1c) or median threshold (n = 52, Supplementary Fig. 2a), thus indicating that poor survival across high versus low PRMT2 groups reflects PRMT2-linked signaling processes.